Westlake Chemical Partners LP Operating Income (Loss) in USD from Q2 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Westlake Chemical Partners LP quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q3 2025.
  • Westlake Chemical Partners LP Operating Income (Loss) for the quarter ending September 30, 2025 was $92M, a 16.1% decline year-over-year.
  • Westlake Chemical Partners LP Operating Income (Loss) for the twelve months ending September 30, 2025 was $322M, a 17.7% decline year-over-year.
  • Westlake Chemical Partners LP annual Operating Income (Loss) for 2024 was $390M, a 9.15% increase from 2023.
  • Westlake Chemical Partners LP annual Operating Income (Loss) for 2023 was $358M, a 2.88% increase from 2022.
  • Westlake Chemical Partners LP annual Operating Income (Loss) for 2022 was $348M, a 15.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Westlake Chemical Partners LP Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $322M $92M -$17.7M -16.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-31
Q2 2025 $340M $91.2M -$2.4M -2.56% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $342M $46.6M -$48.5M -51% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-02
Q4 2024 $390M $92M -$791K -0.85% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-05
Q3 2024 $391M $110M +$23.4M +27.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-31
Q2 2024 $368M $93.6M +$13.1M +16.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $355M $95.1M -$3.06M -3.11% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-02
Q4 2023 $358M $92.8M -$2.46M -2.58% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-05
Q3 2023 $360M $86.2M +$4.42M +5.41% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $356M $80.5M -$6.89M -7.89% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $363M $98.2M +$14.9M +18% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $348M $95.3M -$45.5M -32.3% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-05
Q3 2022 $393M $81.8M +$13.7M +20.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $379M $87.4M -$35.4M -28.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $415M $83.2M +$4.19M +5.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $411M $141M +$63.2M +81.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $348M $68.1M -$26M -27.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $374M $123M +$38.9M +46.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $335M $79M -$18.3M -18.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $353M $77.6M -$18.1M -18.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-02
Q3 2020 $371M $94.1M +$7.74M +8.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $363M $83.9M -$428K -0.51% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $364M $97.4M +$13.7M +16.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $350M $95.8M +$9.3M +10.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $341M $86.4M -$1.6M -1.82% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-02
Q2 2019 $342M $84.3M -$5.42M -6.04% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-02
Q1 2019 $348M $83.7M -$1.69M -1.98% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-02
Q4 2018 $350M $86.5M -$16.5M -16.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $366M $88M -$600K -0.68% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 $367M $89.7M -$2.94M -3.17% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 $370M $85.4M -$4.76M -5.28% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 $374M $103M +$4.41M +4.47% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $370M $88.6M +$7.59M +9.36% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 $362M $92.7M +$10.2M +12.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 $352M $90.1M -$14.2M -13.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 $366M $98.6M +$6.32M +6.85% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $360M $81M -$7.3M -8.27% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 $367M $82.5M -$6M -6.78% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $373M $104M +$14.1M +15.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $359M $92.3M -$3.25M -3.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 $363M $88.3M -$67.8M -43.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-07
Q2 2015 $430M $88.5M -$152M -63.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-07
Q1 2015 $582M $90.2M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-07
Q4 2014 $95.5M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 $156M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 $240M +$8.99M +3.89% Apr 1, 2014 Jun 30, 2014 10-Q 2014-09-08
Q2 2013 $231M Apr 1, 2013 Jun 30, 2013 10-Q 2014-09-08

Westlake Chemical Partners LP Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $390M +$32.7M +9.15% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $358M +$10M +2.88% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $348M -$63M -15.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-05
2021 $411M +$57.7M +16.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $353M +$2.84M +0.81% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $350M +$581K +0.17% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $350M -$24.8M -6.63% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
2017 $374M +$7.96M +2.17% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $366M +$7.11M +1.98% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $359M -$357M -49.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $717M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.